Illumina Ventures

Illumina Ventures Illumina Ventures is the CVC of Illumina, the dominant player in DNA sequencing, managing $560M+ in total AUM with Fund III targeting $200M (reduced from an initial $300M target). Across 51 investments, the portfolio includes foundational genomics companies: Twist Bioscience, CareDx, and Sherlock Biosciences, with 1 unicorn, 2 IPOs, and 12 acquisitions. Recent 2025 investments include Attovia Therapeutics, Infinity Bio, Arima Genomics ($22M Series C led), and NuCicer. The strat